Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Miyamoto

Showing results (91-100 of 219) with videos related to

Pageof 22
Sort By:
Japanese Journal of Clinical Oncology|January 23, 2019
Validation of the Integrated Palliative care Outcome Scale (IPOS) - Japanese VersionHiroki Sakurai, Mitsunori Miyashita, Kengo Imai, et al.
Gynecologic Oncology|June 10, 2005
Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancerKenzo Sonoda, Shingo Miyamoto, Toshio Hirakawa, et al.
Biochemical and Biophysical Research Communications|December 17, 2017
Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cellsShingo Miyamoto, Yuko Nagamura, Ayaka Nakabo, et al.
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|June 29, 2016
Effects of NSAIDs on the risk factors of colorectal cancer: a mini reviewTakahiro Hamoya, Gen Fujii, Shingo Miyamoto, et al.
Frontiers in Bioscience (Scholar Edition)|May 31, 2011
Dietary flavonoids as cancer-preventive and therapeutic biofactorsShin Nishiumi, Shingo Miyamoto, Kyuichi Kawabata, et al.
Biology of Reproduction|February 28, 2003
TNFalpha-induced apoptosis and integrin switching in human extravillous trophoblast cell lineKotaro Fukushima, Shingo Miyamoto, Hajime Komatsu, et al.
Cancer Science|June 3, 2011
Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenograftsYasuko Naganuma, Batsuren Choijamts, Kyoko Shirota, et al.
Anticancer Research|November 1, 2007
New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting moleculeShingo Miyamoto, Hiroshi Yagi, Fusanori Yotsumoto, et al.
Nutrition and Cancer|October 12, 2007
9trans,11trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in ratsYumiko Yasui, Rikako Suzuki, Hiroyuki Kohno, et al.
Gynecologic Oncology|August 23, 2005
Invasive potency related to RCAS1 expression in uterine cervical cancerKenzo Sonoda, Shingo Miyamoto, Toshio Hirakawa, et al.
Pageof 22

Showing results (91-100 of 219) with videos related to

Sort By:
Pageof 22
Japanese Journal of Clinical Oncology|January 23, 2019
Validation of the Integrated Palliative care Outcome Scale (IPOS) - Japanese VersionHiroki Sakurai, Mitsunori Miyashita, Kengo Imai, et al.
Gynecologic Oncology|June 10, 2005
Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancerKenzo Sonoda, Shingo Miyamoto, Toshio Hirakawa, et al.
Biochemical and Biophysical Research Communications|December 17, 2017
Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cellsShingo Miyamoto, Yuko Nagamura, Ayaka Nakabo, et al.
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|June 29, 2016
Effects of NSAIDs on the risk factors of colorectal cancer: a mini reviewTakahiro Hamoya, Gen Fujii, Shingo Miyamoto, et al.
Frontiers in Bioscience (Scholar Edition)|May 31, 2011
Dietary flavonoids as cancer-preventive and therapeutic biofactorsShin Nishiumi, Shingo Miyamoto, Kyuichi Kawabata, et al.
Biology of Reproduction|February 28, 2003
TNFalpha-induced apoptosis and integrin switching in human extravillous trophoblast cell lineKotaro Fukushima, Shingo Miyamoto, Hajime Komatsu, et al.
Cancer Science|June 3, 2011
Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenograftsYasuko Naganuma, Batsuren Choijamts, Kyoko Shirota, et al.
Anticancer Research|November 1, 2007
New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting moleculeShingo Miyamoto, Hiroshi Yagi, Fusanori Yotsumoto, et al.
Nutrition and Cancer|October 12, 2007
9trans,11trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in ratsYumiko Yasui, Rikako Suzuki, Hiroyuki Kohno, et al.
Gynecologic Oncology|August 23, 2005
Invasive potency related to RCAS1 expression in uterine cervical cancerKenzo Sonoda, Shingo Miyamoto, Toshio Hirakawa, et al.
Pageof 22